To evaluate the effectiveness of a digital medication system in improving adherence among patients with serious mental disorders (SMD), we conducted a cluster-randomized controlled trial across 30 communities in Beijing. Participants, aged 18–65 years,…
Continue Reading
Brittany Erana, CEO at Jumo Health
What You Should Know:
– Jumo Health, a global leader in optimizing the patient experience in clinical trials announced the appointment of Brittany Erana as its new Chief Executive Officer.
–…
Continue Reading
We employed a three-phase approach, culminating in a randomized controlled trial, to assess the efficacy of 3D-printed liver models in hepatobiliary surgical planning. Phase one involved developing and selecting 35 optimal 3DP models based…
Continue Reading
Clinical practice is currently guided by studies that average over patient outcomes. This may not be the best approach, as different patients may have different treatment responses. Here we extend a method for simulating…
Continue Reading
Background: Patients undergoing major surgery are at risk of complications and delayed recovery. Prehabilitation has shown promise in improving postoperative outcomes. Offering prehabilitation by means of mHealth can help overcome barriers for participating in…
Continue Reading
Medication adherence is crucial for slowing chronic kidney disease (CKD) progression. A specially designed pharmacist-led mobile application, Kidney Health, was evaluated in a single-center, prospective, 3 months, randomized controlled trial (RCT) to assess its…
Continue Reading
Background: As the population ages, the prevalence of chronic diseases such as arterial hypertension (AH) and type 2 diabetes (T2D) is increasing, posing challenges for effective management in primary care settings. Although mobile health…
Continue Reading
Background: Mobile health (mHealth) has been continuously developed to support the HIV care continuum for people living with HIV (PLWH). Considering the practical needs and acceptability of digital health solutions, it is essential to…
Continue Reading
Brooklyn Health, a neuroscience technology company, secured $6.5 million in seed funding. The round was led by HealthX, with participation from Metrodora Ventures, Story Ventures, RiverPark Ventures, Laconia Capital, Everywhere Ventures, Hypothesis Studio and Blue…
Continue Reading
What You Should Know:
– Brooklyn Health, a neuroscience technology company focused on objective measurement of mental health announced it has secured $6.5M in seed funding led by HealthX, with participation from Metrodora Ventures, Story…
Continue Reading
